The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Large-scale production of human pluripotent stem cell derived cardiomyocytes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Coupled with in-process heterogeneity and the evolving regulatory framework surrounding assessment of stem-cell-derived therapeutics, it is difficult to develop scalable, robust processes that are strictly standardized and economically viable4,5.”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717
Chemically defined generation of human cardiomyocytes
Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N. M., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2999 · Cited by 1,606
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389
Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., & Keller, G. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.008 · Cited by 1,159
He, J.-Q., Ma, Y., Lee, Y., Thomson, J. A., & Kamp, T. J. (2003) · Circulation Research · doi:10.1161/01.res.0000080317.92718.99 · Cited by 800
Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Lundy, S. D., Zhu, W.-Z., Regnier, M., & Laflamme, M. A. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0490 · Cited by 738
Wang, X., Wang, Y., Wu, X., Wang, J., Wang, Y., Qiu, Z., Chang, T., Huang, H., Lin, R.-J., & Yee, J.-K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3127 · Cited by 442
Orlova, V. V., van den Hil, F. E., Petrus-Reurer, S., Drabsch, Y., ten Dijke, P., & Mummery, C. L. (2014) · Nature Protocols · doi:10.1038/nprot.2014.102 · Cited by 365
Research works printed but not linked: 139
- Zweigerdt, 2007, The art of cobbling a running pump—will human embryonic stem cells mend broken hearts?, Semin. Cell Dev. Biol., 18, 794, 10.1016/j.semcdb.2007.09.014 · DOI
- Soonpaa, 2013, Challenges measuring cardiomyocyte renewal, Biochim. Biophys. Acta, 1833, 799, 10.1016/j.bbamcr.2012.10.029 · DOI
- van Berlo, 2014, c-kit+cells minimally contribute cardiomyocytes to the heart, Nature, 509, 337, 10.1038/nature13309 · DOI · Paper page
- Rojas, 2015, A new era of ventricular assist device surgery: less invasive procedures, Minerva Chir., 70, 63
- Murry, 2005, Cell-based cardiac repair: reflections at the 10-year point, Circulation, 112, 3174, 10.1161/CIRCULATIONAHA.105.546218 · DOI · Paper page
- Donndorf, 2013, Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease, Curr. Pharm. Biotechnol., 14, 12
- Parsa, 2016, Bioengineering methods for myocardial regeneration, Adv. Drug Deliv. Rev, 96, 195, 10.1016/j.addr.2015.06.012 · DOI
- Masuda, 2016, Three-dimensional cardiac tissue fabrication based on cell sheet technology, Adv. Drug Deliv. Rev, 96, 103, 10.1016/j.addr.2015.05.002 · DOI
- Liaw, 2016, Mechanical stimulation in the engineering of heart muscle, Adv. Drug Deliv. Rev, 96, 156, 10.1016/j.addr.2015.09.001 · DOI
- Templin, 2012, Circulation, 126, 430, 10.1161/CIRCULATIONAHA.111.087684 · DOI · Paper page
- Ye, 2014, Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells, Cell Stem Cell, 15, 750, 10.1016/j.stem.2014.11.009 · DOI · Paper page
- Lian, 2014, Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling, Stem Cell Rep., 3, 804, 10.1016/j.stemcr.2014.09.005 · DOI · Paper page
- Dar, 2012, Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb, Circulation, 125, 87, 10.1161/CIRCULATIONAHA.111.048264 · DOI · Paper page
- Patsch, 2015, Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells, Nat. Cell Biol., 17, 994, 10.1038/ncb3205 · DOI · Paper page
- Chen, 2011, Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs, J. Transl. Med., 9, 47, 10.1186/1479-5876-9-47 · DOI · Paper page
- Kempf, 2014, Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture, Stem Cell Rep., 3, 1132, 10.1016/j.stemcr.2014.09.017 · DOI · Paper page
- Zweigerdt, 2009, Large scale production of stem cells and their derivatives, Adv. Biochem. Eng. Biotechnol., 114, 201
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
- Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
- Tanaka, 2015, Cardiovascular disease modeling using patient-specific induced pluripotent stem cells, Int. J. Mol. Sci., 16, 18894, 10.3390/ijms160818894 · DOI
- Fatima, 2013, The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients, PLoS One, 8, e83005, 10.1371/journal.pone.0083005 · DOI
- Schwartz, 2012, Embryonic stem cell trials for macular degeneration: a preliminary report, Lancet, 379, 713, 10.1016/S0140-6736(12)60028-2 · DOI · Paper page
- Menasche, 2015, Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience, Eur. Heart J., 36, 743, 10.1093/eurheartj/ehu192 · DOI · Paper page
- Okita, 2011, Immunogenicity of induced pluripotent stem cells, Circ. Res., 109, 720, 10.1161/RES.0b013e318232e187 · DOI
- Zhao, 2011, Immunogenicity of induced pluripotent stem cells, Nature, 474, 212, 10.1038/nature10135 · DOI · Paper page
- Araki, 2013, Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells, Nature, 494, 100, 10.1038/nature11807 · DOI · Paper page
- de Almeida, 2014, Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance, Nat. Commun., 5, 3903, 10.1038/ncomms4903 · DOI · Paper page
- Zhao, 2015, Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells, Cell Stem Cell, 17, 353, 10.1016/j.stem.2015.07.021 · DOI · Paper page
- Reardon, 2014, Japan stem-cell trial stirs envy, Nature, 513, 287, 10.1038/513287a · DOI
- Jenkins, 2015, Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies, Biotechnol. J., 10, 83, 10.1002/biot.201400348 · DOI · Paper page
- Zimmermann, 2012, Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations, Stem Cells Dev., 21, 2364, 10.1089/scd.2012.0088 · DOI
- Haase, 2009, Generation of induced pluripotent stem cells from human cord blood, Cell Stem Cell, 5, 434, 10.1016/j.stem.2009.08.021 · DOI · Paper page
- Chen, 2015, Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells, Stem Cell Res., 15, 365, 10.1016/j.scr.2015.08.002 · DOI · Paper page
- Chu, 2001, Industrial choices for protein production by large-scale cell culture, Curr. Opin. Biotechnol., 12, 180, 10.1016/S0958-1669(00)00197-X · DOI · Paper page
- Mummery, 2012, Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview, Circ. Res., 111, 344, 10.1161/CIRCRESAHA.110.227512 · DOI · Paper page
- Amit, 2010, Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells, Stem Cell Rev., 6, 248, 10.1007/s12015-010-9149-y · DOI
- Konze, 2014, Cleavage of E-cadherin and beta-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells, Mol. Cell. Proteomics, 13, 990, 10.1074/mcp.M113.033423 · DOI
- Lei, 2013, A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation, Proc. Natl. Acad. Sci. U. S. A., 110, E5039, 10.1073/pnas.1309408110 · DOI · Paper page
- Lou, 2014, The use of nanofibrillar cellulose hydrogel as a flexible three-dimensional model to culture human pluripotent stem cells, Stem Cells Dev., 23, 380, 10.1089/scd.2013.0314 · DOI · Paper page
- Celiz, 2014, Materials for stem cell factories of the future, Nat. Mater., 13, 570, 10.1038/nmat3972 · DOI · Paper page
- Zweigerdt, 2003, Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies, Cytotherapy, 5, 399, 10.1080/14653240310003062 · DOI
- Zweigerdt, 2011, Scalable expansion of human pluripotent stem cells in suspension culture, Nat. Protoc., 6, 689, 10.1038/nprot.2011.318 · DOI · Paper page
- Otsuji, 2014, A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production, Stem Cell Rep., 2, 734, 10.1016/j.stemcr.2014.03.012 · DOI
- Olmer, 2012, Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors, Tissue Eng. Part C Methods, 18, 772, 10.1089/ten.tec.2011.0717 · DOI · Paper page
- dos Santos, 2013, Bioreactor design for clinical-grade expansion of stem cells, Biotechnol. J., 8, 644, 10.1002/biot.201200373 · DOI
- Ilin, 2015, Secondary ion mass spectrometry and Raman spectroscopy for tissue engineering applications, Curr. Opin. Biotechnol., 31, 108, 10.1016/j.copbio.2014.10.011 · DOI
- Lorbeer, 2011, Highly efficient 3D fluorescence microscopy with a scanning laser optical tomograph, Opt. Express, 19, 5419, 10.1364/OE.19.005419 · DOI
- Fong, 2005, Perfusion cultures of human embryonic stem cells, Bioprocess Biosyst. Eng., 27, 381, 10.1007/s00449-005-0421-5 · DOI
- Serra, 2010, Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control, J. Biotechnol., 148, 208, 10.1016/j.jbiotec.2010.06.015 · DOI
- Phillips, 2008, Efficient expansion of clinical-grade human fibroblasts on microcarriers: cells suitable for ex vivo expansion of clinical-grade hESCs, J. Biotechnol., 134, 79, 10.1016/j.jbiotec.2007.12.007 · DOI
- Oh, 2009, Long-term microcarrier suspension cultures of human embryonic stem cells, Stem Cell Res., 2, 219, 10.1016/j.scr.2009.02.005 · DOI · Paper page
- Kleger, 2010, Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells, Circulation, 122, 1823, 10.1161/CIRCULATIONAHA.110.971721 · DOI
- Silva, 2015, Robust expansion of human pluripotent stem cells: integration of bioprocess design with transcriptomic and metabolomic characterization, Stem Cells Transl. Med., 4, 731, 10.5966/sctm.2014-0270 · DOI
- Polykandriotis, 2008, To matrigel or not to matrigel, Am. J. Pathol., 172, 1441, 10.2353/ajpath.2008.071215 · DOI
- Ellerstrom, 2007, Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation, Stem Cells, 25, 1690, 10.1634/stemcells.2006-0607 · DOI
- Amit, 2011, Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells, Nat. Protoc., 6, 572, 10.1038/nprot.2011.325 · DOI
- Olmer, 2010, Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium, Stem Cell Res., 5, 51, 10.1016/j.scr.2010.03.005 · DOI · Paper page
- Singh, 2010, Up-scaling single cell-inoculated suspension culture of human embryonic stem cells, Stem Cell Res., 4, 165, 10.1016/j.scr.2010.03.001 · DOI · Paper page
- Wang, 2007, Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling, Blood, 110, 4111, 10.1182/blood-2007-03-082586 · DOI · Paper page
- Chen, 2012, Scalable GMP compliant suspension culture system for human ES cells, Stem Cell Res., 8, 388, 10.1016/j.scr.2012.02.001 · DOI
- Wang, 2013, Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions, Stem Cell Res., 11, 1103, 10.1016/j.scr.2013.07.011 · DOI
- Hunt, 2014, Factorial experimental design for the culture of human embryonic stem cells as aggregates in stirred suspension bioreactors reveals the potential for interaction effects between bioprocess parameters, Tissue Eng. Part C Methods, 20, 76, 10.1089/ten.tec.2013.0040 · DOI
- Abbasalizadeh, 2012, Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor, Tissue Eng. Part C Methods, 18, 831, 10.1089/ten.tec.2012.0161 · DOI
- Kehat, 2001, Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes, J. Clin. Invest., 108, 407, 10.1172/JCI200112131 · DOI
- Mummery, 2003, Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells, Circulation, 107, 2733, 10.1161/01.CIR.0000068356.38592.68 · DOI · Paper page
- Burridge, 2012, Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming, Cell Stem Cell, 10, 16, 10.1016/j.stem.2011.12.013 · DOI · Paper page
- Laflamme, 2007, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts, Nat. Biotechnol., 25, 1015, 10.1038/nbt1327 · DOI · Paper page
- Burridge, 2011, A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability, PLoS One, 6, e18293, 10.1371/journal.pone.0018293 · DOI · Paper page
- Elliott, 2011, NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes, Nat. Methods, 8, 1037, 10.1038/nmeth.1740 · DOI · Paper page
- Kawamura, 2012, Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model, Circulation, 126, S29, 10.1161/CIRCULATIONAHA.111.084343 · DOI · Paper page
- Freund, 2008, Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells, Stem Cells, 26, 724, 10.1634/stemcells.2007-0617 · DOI
- Xu, 2008, Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells, Differentiation, 76, 958, 10.1111/j.1432-0436.2008.00284.x · DOI · Paper page
- Passier, 2005, Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures, Stem Cells, 23, 772, 10.1634/stemcells.2004-0184 · DOI · Paper page
- Graichen, 2008, Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK, Differentiation, 76, 357, 10.1111/j.1432-0436.2007.00236.x · DOI · Paper page
- Gaur, 2010, Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes, Cytotherapy, 12, 807, 10.3109/14653249.2010.491821 · DOI
- Kempf, 2011, Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells, Stem Cell Res., 7, 198, 10.1016/j.scr.2011.06.001 · DOI
- Ueno, 2007, Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells, Proc. Natl. Acad. Sci. U. S. A., 104, 9685, 10.1073/pnas.0702859104 · DOI · Paper page
- Ren, 2011, Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells, J. Mol. Cell. Cardiol., 51, 280, 10.1016/j.yjmcc.2011.04.012 · DOI
- Willems, 2011, Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm, Circ. Res., 109, 360, 10.1161/CIRCRESAHA.111.249540 · DOI · Paper page
- Hudson, 2012, Primitive cardiac cells from human embryonic stem cells, Stem Cells Dev., 21, 1513, 10.1089/scd.2011.0254 · DOI
- Minami, 2012, A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions, Cell Rep., 2, 1448, 10.1016/j.celrep.2012.09.015 · DOI · Paper page
- Gonzalez, 2011, Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells, Angew. Chem., 50, 11181, 10.1002/anie.201103909 · DOI
- David, 2008, MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling, Nat. Cell Biol., 10, 338, 10.1038/ncb1696 · DOI · Paper page
- Lian, 2013, Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions, Nat. Protoc., 8, 162, 10.1038/nprot.2012.150 · DOI · Paper page
- Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
- Ting, 2014, Time-resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays, Biotechnol. J., 9, 675, 10.1002/biot.201300262 · DOI
- Rust, 2009, Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression, Regen. Med., 4, 225, 10.2217/17460751.4.2.225 · DOI
- Van Hoof, 2010, Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes, J. Proteome Res., 9, 1610, 10.1021/pr901138a · DOI
- Dubois, 2011, SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells, Nat. Biotechnol., 29, 1011, 10.1038/nbt.2005 · DOI · Paper page
- Uosaki, 2011, Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression, PLoS One, 6, e23657, 10.1371/journal.pone.0023657 · DOI · Paper page
- Davis, 2008, Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors, Blood, 111, 1876, 10.1182/blood-2007-06-093609 · DOI · Paper page
- Fujiwara, 2011, Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A, PLoS One, 6, e16734, 10.1371/journal.pone.0016734 · DOI
- Blin, 2010, A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates, J. Clin. Invest., 120, 1125, 10.1172/JCI40120 · DOI · Paper page
- Leschik, 2008, Cardiac commitment of primate embryonic stem cells, Nat. Protoc., 3, 1381, 10.1038/nprot.2008.116 · DOI
- Evseenko, 2010, Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells, Proc. Natl. Acad. Sci. U. S. A., 107, 13742, 10.1073/pnas.1002077107 · DOI · Paper page
- Ardehali, 2013, Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue, Proc. Natl. Acad. Sci. U. S. A., 110, 3405, 10.1073/pnas.1220832110 · DOI
- Den Hartogh, 2015, Dual reporter MESP1–NKX2-5 hESCs enable studying early human cardiac differentiation, Stem Cells, 33, 56, 10.1002/stem.1842 · DOI
- Bu, 2009, Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages, Nature, 460, 113, 10.1038/nature08191 · DOI · Paper page
- Ritner, 2011, An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors, PLoS One, 6, e16004, 10.1371/journal.pone.0016004 · DOI
- Huber, 2007, Identification and selection of cardiomyocytes during human embryonic stem cell differentiation, FASEB J., 21, 2551, 10.1096/fj.05-5711com · DOI · Paper page
- Ovchinnikov, 2015, Isolation of contractile cardiomyocytes from human pluripotent stem-cell-derived cardiomyogenic cultures using a human NCX1-EGFP reporter, Stem Cells Dev., 24, 11, 10.1089/scd.2014.0195 · DOI
- Lock, 2009, Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture, Tissue Eng. A, 15, 2051, 10.1089/ten.tea.2008.0455 · DOI · Paper page
- Vosough, 2013, Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture, Stem Cells Dev., 22, 2693, 10.1089/scd.2013.0088 · DOI
- Niebruegge, 2009, Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor, Biotechnol. Bioeng., 102, 493, 10.1002/bit.22065 · DOI · Paper page
- Haraguchi, 2013, Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering, J. Tissue Eng. Regen. Med.
- Lecina, 2010, Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures, Tissue Eng. Part C Methods, 16, 1609, 10.1089/ten.tec.2010.0104 · DOI
- Ting, 2014, An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures, Stem Cell Res., 13, 202, 10.1016/j.scr.2014.06.002 · DOI
- Kempf, 2015, Cardiac differentiation of human pluripotent stem cells in scalable suspension culture, Nat. Protoc., 10, 1345, 10.1038/nprot.2015.089 · DOI · Paper page
- Chong, 2014, Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts, Nature, 510, 273, 10.1038/nature13233 · DOI · Paper page
- Schroeder, 2005, Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control, Biotechnol. Bioeng., 92, 920, 10.1002/bit.20668 · DOI · Paper page
- Niebruegge, 2008, Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes, Tissue Eng. A, 14, 1591, 10.1089/ten.tea.2007.0247 · DOI
- Fridley, 2012, Hydrodynamic modulation of pluripotent stem cells, Stem Cell Res. Ther., 3, 45, 10.1186/scrt136 · DOI
- Burridge, 2007, Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability, Stem Cells, 25, 929, 10.1634/stemcells.2006-0598 · DOI · Paper page
- Mohr, 2010, The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells, Biomaterials, 31, 1885, 10.1016/j.biomaterials.2009.11.033 · DOI · Paper page
- Dahlmann, 2013, The use of agarose microwells for scalable embryoid body formation and cardiac differentiation of human and murine pluripotent stem cells, Biomaterials, 34, 2463, 10.1016/j.biomaterials.2012.12.024 · DOI
- Hentze, 2009, Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies, Stem Cell Res., 2, 198, 10.1016/j.scr.2009.02.002 · DOI · Paper page
- Hattori, 2010, Nongenetic method for purifying stem cell-derived cardiomyocytes, Nat. Methods, 7, 61, 10.1038/nmeth.1403 · DOI · Paper page
- Ban, 2013, Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA, Circulation, 128, 1897, 10.1161/CIRCULATIONAHA.113.004228 · DOI
- Miki, 2015, Efficient detection and purification of cell populations using synthetic microRNA switches, Cell Stem Cell, 16, 699, 10.1016/j.stem.2015.04.005 · DOI · Paper page
- Tohyama, 2013, Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes, Cell Stem Cell, 12, 127, 10.1016/j.stem.2012.09.013 · DOI · Paper page
- Fuerstenau-Sharp, 2015, Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells, PLoS One, 10, e0126596, 10.1371/journal.pone.0126596 · DOI
- Schwanke, 2014, Fast and efficient multitransgenic modification of human pluripotent stem cells, Hum. Gene Ther. Methods, 25, 136, 10.1089/hgtb.2012.248 · DOI
- Merkert, 2014, Efficient designer nuclease-based homologous recombination enables direct PCR screening for footprintless targeted human pluripotent stem cells, Stem Cell Rep., 2, 107, 10.1016/j.stemcr.2013.12.003 · DOI
- Klug, 1996, Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts, J. Clin. Invest., 98, 216, 10.1172/JCI118769 · DOI · Paper page
- Anderson, 2007, Transgenic enrichment of cardiomyocytes from human embryonic stem cells, Mol. Ther., 15, 2027, 10.1038/sj.mt.6300303 · DOI · Paper page
- Xu, 2008, Highly enriched cardiomyocytes from human embryonic stem cells, Cytotherapy, 10, 376, 10.1080/14653240802105307 · DOI
- Martin, 2015, New muscle for old hearts: engineering tissue from pluripotent stem cells, Hum. Gene Ther., 26, 305, 10.1089/hum.2015.022 · DOI
- Xu, 2009, Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells, Stem Cells, 27, 2163, 10.1002/stem.166 · DOI · Paper page
- Sartiani, 2007, Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach, Stem Cells, 25, 1136, 10.1634/stemcells.2006-0466 · DOI · Paper page
- Yang, 2014, Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells, J. Mol. Cell. Cardiol., 72, 296, 10.1016/j.yjmcc.2014.04.005 · DOI · Paper page
- Feric, 2016, Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells, Adv. Drug Deliv. Rev, 96, 110, 10.1016/j.addr.2015.04.019 · DOI · Paper page
- Stoppel, 2016, Electrical and mechanical stimulation of cardiac cells and tissue constructs, Adv. Drug Deliv. Rev, 96, 135, 10.1016/j.addr.2015.07.009 · DOI · Paper page
- Kraushaar, 2012, Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models, Expert Opin. Drug Saf., 11, 285, 10.1517/14740338.2012.639358 · DOI
- Karakikes, 2015, Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes, Circ. Res., 117, 80, 10.1161/CIRCRESAHA.117.305365 · DOI · Paper page
- Lundy, 2014, Cell-based delivery of dATP via gap junctions enhances cardiac contractility, J. Mol. Cell. Cardiol., 72, 350, 10.1016/j.yjmcc.2014.04.010 · DOI
- Sekine, 2014, Oxygen consumption of human heart cells in monolayer culture, Biochem. Biophys. Res. Commun., 452, 834, 10.1016/j.bbrc.2014.09.018 · DOI
- Mauritz, 2011, Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction, Eur. Heart J., 32, 2634, 10.1093/eurheartj/ehr166 · DOI
- Birket, 2015, Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells, Nat. Biotechnol., 33, 970, 10.1038/nbt.3271 · DOI · Paper page
Cited by
Progress and challenges in large-scale expansion of human pluripotent stem cells
Kropp, C., Massai, D., & Zweigerdt, R. (2017) · Process Biochemistry · doi:10.1016/j.procbio.2016.09.032 · Cited by 167
Self-citationCorreia, C., Koshkin, A., Duarte, P., Hu, D., Carido, M., Sebastião, M. J., Gomes‐Alves, P., Elliott, D. A., Domian, I. J., Teixeira, A. P., et al. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26504 · Cited by 139
Colter, J., Murari, K., Biernaskie, J., & Kallos, M. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00183-7 · Cited by 33
Metadata
- Authors
- Kempf, H., Andree, B., & Zweigerdt, R.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 96
- Pages
- 18-30
- ISSN
- 0169-409X
- Cited by
- 108
- References
- 17
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- German Research Foundation (DFG EXC62/3, ZW 64/4-1)
- German Ministry for Education and Science (13N12606)
- Innovative Medicines Initiative Joint Undertaking (115439-2)
- European Union (FP7/2007-2013)
- EFPIA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Large-scale production of human pluripotent stem cell derived cardiomyocytes. https://app.cochat.ai/papers/10.1016/j.addr.2015.11.016
- The paper
- Kempf, H., Andree, B., & Zweigerdt, R. (2016). Large-scale production of human pluripotent stem cell derived cardiomyocytes. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2015.11.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.